Altamira Therapeutics (CYTO) stock forecast for 2022. Forecast tables and graphs.

Altamira Therapeutics (CYTO) stock forecast for 2022

Last update: September 23, 2023 (10:41)

Sector: Healthcare

The share price of Altamira Therapeutics Ltd. (CYTO) now

What analysts predict: $None
52-week High/Low: $13.52 / $0.23

50/200 Day Moving Average: $0.424 / $2.124

This figure corresponds to the Average Price over the previous 50/200 days. For Altamira Therapeutics stocks, the 50-day moving average is the resistance level today.

For Altamira Therapeutics stocks, the 200-day moving average is the resistance level today.

Are you interested in Altamira Therapeutics stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Altamira Therapeutics stock price in 2022. How much will one Altamira Therapeutics share be worth in 2022? Is it worth taking profit / loss on Altamira Therapeutics stock now or waiting? What are analysts' forecasts for Altamira Therapeutics stock?

We forecast Altamira Therapeutics stock performance using neural networks based on historical data on Altamira Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. The Altamira Therapeutics stock prediction results are shown below and presented as a graph, table and text information.

Altamira Therapeutics stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for Altamira Therapeutics analysts is $None.

Today 200 Day Moving Average is the resistance level (2.124 $).

50 Day Moving Average is the resistance level (0.424 $).

Historical and forecast chart of Altamira Therapeutics stock

The chart below shows the historical price of Altamira Therapeutics stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Altamira Therapeutics stock price can be found in the table below.

Altamira Therapeutics (CYTO) Forecast for 2022

Month Target Pes. Opt. Vol., %

Altamira Therapeutics information and performance

Altamira Therapeutics Ltd is committed to the development of therapeutic agents to address unmet medical needs. It is active in the treatment of RNA, allergies and viral infections, as well as in diseases of the inner ear. Bentrio is a drug-free nasal spray for personal protection against airborne viruses and allergens.

Altamira Therapeutics Address


Market Capitalization: 2 895 300 $

Market capitalization of the Altamira Therapeutics Ltd. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of CYTO shares in the company outstanding by the market price of one share.

EBITDA: -13 688 696 $

EBITDA of Altamira Therapeutics is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth


Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.


Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -30.34

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 8.62

Enterprise Value (EV) /Revenue

EV To EBITDA: -0.636

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 7954000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Altamira Therapeutics price target for 2022 by month

Altamira Therapeutics (CYTO) stock dividend

Altamira Therapeutics last paid dividends on 01/01/1970. The next scheduled payment will be on 05/01/2019. The amount of dividends is $0 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.

Last Split Factor:

Last Split Date: 01/01/1970

Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.

For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.

Related stocks from Healthcare sector


All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.